Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001446580-25-000071
Filing Date
2025-08-14
Accepted
2025-08-14 10:30:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 11177
2 JOINT FILING AGREEMENT med_sc13g-ex99.htm EX-99 1641
  Complete submission text file 0001446580-25-000071.txt   14915
Mailing Address 100 INTERNATIONAL DRIVE 18TH FLOOR BALTIMORE MD 21202
Business Address 100 INTERNATIONAL DRIVE 18TH FLOOR BALTIMORE MD 21202 4105818042
MEDIFAST INC (Subject) CIK: 0000910329 (see all company filings)

EIN.: 133714405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-50217 | Film No.: 251215322
SIC: 2090 Miscellaneous Food Preparations & Kindred Products
(CF Office: 04 Manufacturing)

Mailing Address 401 CITY AVENUE, SUITE 220 BALA CYNWYD PA 19004
Business Address 401 CITY AVENUE, SUITE 220 BALA CYNWYD PA 19004 610-617-2600
SUSQUEHANNA SECURITIES, LLC (Filed by) CIK: 0001446580 (see all company filings)

EIN.: 232754552
Type: SCHEDULE 13G